• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is NewMed Energy Limited Partnership (TASE:NWMD) Below Fair Value As Strong Q2 Earnings Land?

    Simply Wall St·08/13/2026 14:30:21
    Listen to the news

    Q2 2026 earnings highlight mixed picture for NewMed Energy, Limited Partnership

    NewMed Energy, Limited Partnership (TASE:NWMD) reported Q2 2026 revenue of US$250.1 million and net income of US$117.8 million, with basic earnings per share from continuing operations at US$0.094.

    See our latest analysis for NewMed Energy - Limited Partnership.

    NewMed Energy, Limited Partnership shares closed at ₪16.2, with a 1 month share price return of 3.38%. The 1 year total shareholder return of 7.70% and 5 year total shareholder return of 392.84% point to strong longer term momentum, despite a 3 month share price decline of 8.99% and a year to date share price decline of 12.05%.

    If you are looking for more ideas in the energy space, this could be a good moment to see which other producers are attracting fresh interest through 90 nuclear energy infrastructure stocks

    After the recent share price pullback, NewMed Energy, Limited Partnership trades below both analyst targets and some intrinsic value estimates. Is the gap a genuine margin of safety, or a signal that expectations need adjusting?

    Most Popular Narrative: 9.5% Undervalued

    NewMed Energy, Limited Partnership last closed at ₪16.2, while the most followed narrative places fair value at ₪17.9, using an 8.51% discount rate to reach that figure.

    Heavy capital commitments to Leviathan phase two, Aphrodite and multiple midstream projects cluster large spending into the next few years. This can pressure free cash flow and limit flexibility if gas demand or realized prices soften, with potential knock on effects for earnings.

    Read the complete narrative. Read the complete narrative.

    The fair value story for NewMed Energy, Limited Partnership depends on how revenue and earnings change over time, how margins evolve, and which future profit multiple investors are willing to pay. The balance of those assumptions, rather than today’s share price moves, is what drives the ₪17.9 figure.

    Result: Fair Value of ₪17.9 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, NewMed Energy, Limited Partnership still faces meaningful risks, including heavy Leviathan and Aphrodite capital spending and geopolitical disruptions that could pressure cash flow and earnings quality.

    Find out about the key risks to this NewMed Energy - Limited Partnership narrative.

    Next Steps

    With both risks and rewards in view for NewMed Energy, Limited Partnership, this is a good moment to review the data yourself and form an independent view. To weigh those concerns against the potential upsides in one place, take a closer look at the 2 key rewards and 3 important warning signs.

    Looking for more investment ideas beyond NewMed Energy, Limited Partnership?

    If you are serious about building a stronger portfolio, do not stop with NewMed Energy, Limited Partnership. Use focused stock lists to spot opportunities others might overlook.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.